Gut-Microbiome Implications in Opioid Use Disorder and Related Behaviors
Overview
Authors
Affiliations
Substance use disorder (SUD) is a prevalent disease that has caused hundreds of thousands of deaths and affected the lives of even more. Despite its global impact, there is still no known cure for SUD, or the psychological symptoms associated with drug use. Many of the behavioral consequences of drug use prevent people from breaking the cycle of addiction or cause them to relapse back into the cycle due to the physical and psychological consequences of withdrawal. Current research is aimed at understanding the cause of these drug related behaviors and therapeutically targeting them as a mechanism to break the addiction cycle. Research on opioids suggests that the changes in the microbiome during drug use modulated drug related behaviors and preventing these microbial changes could attenuate behavioral symptoms. This review aims to highlight the relationship between the changes in the microbiome and behavior during opioid treatment, as well as highlight the additional research needed to understand the mechanism in which the microbiome modulates behavior to determine the best therapeutic course of action.
Baslam A, Azraida H, Aboufatima R, Ait-El-Mokhtar M, Dilagui I, Boussaa S Antioxidants (Basel). 2024; 13(1).
PMID: 38275646 PMC: 10812446. DOI: 10.3390/antiox13010026.
Beyond the Syndemic of Opioid Use Disorders and HIV: The Impact of Opioids on Viral Reservoirs.
Trunfio M, Chaillon A, Beliakova-Bethell N, Deiss R, Letendre S, Riggs P Viruses. 2023; 15(8).
PMID: 37632053 PMC: 10458944. DOI: 10.3390/v15081712.
Tsigalou C, Paraschaki A, Bragazzi N, Aftzoglou K, Bezirtzoglou E, Tsakris Z Front Cell Infect Microbiol. 2023; 13:1191126.
PMID: 37333847 PMC: 10272562. DOI: 10.3389/fcimb.2023.1191126.